Cardiovascular safety of febuxostat - Authors' reply

Lancet. 2021 Sep 11;398(10304):955-956. doi: 10.1016/S0140-6736(21)01383-0.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Febuxostat* / adverse effects
  • Gout Suppressants / adverse effects
  • Gout* / drug therapy
  • Humans

Substances

  • Gout Suppressants
  • Febuxostat